Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
20,321 articlesA bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
A fresh institutional stake in PENN Entertainment signals shifting sentiment in a dynamic gaming landscape. This deep...
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
Chasing big gains in the market is tough. Some growth-focused ETFs have quietly outperformed Vanguard's broad-market ...
In the AI boom, everyone chase chips and models. But the most important company you've probably never heard of sits b...
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
With market volatility on the rise, investors are turning to high-yield dividend plays. Three U.S. names stand out fo...
A little-known small-cap stock is quietly delivering standout performance in 2026. This article breaks down why it ha...
The shift in AI spending is reshaping winners and losers. This article explains why a power-semiconductor-focused com...
GE Vernova's stock slide today highlights how AI data center growth and sector volatility interact with broader marke...
A long standing trading rule is gone, and it could change how millions of small investors trade. This shift may lift ...
Two traditional industrial leaders have surged while Tesla faced a bumpy year. This deep dive explains how Caterpilla...